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introduction 
According to data from the International Diabetes Federation 
(IDF), 10.1% of all 20-79 year olds in Malta suffer from 
T2DM.1 Moreover, it is estimated that there are a further 12,000 
undiagnosed diabetics in the Maltese population. Such data 
signifies the importance of devising strategies to prevent diabetes 
in order to control the morbidity and mortality which is brought 
about by its various complications. The most effective way to 
prevent the onset of diabetes is to work at the community level. 
This means that primary care has a crucial role in preventing 
this chronic condition. Patients suffering from diabetes should 
be empowered to be more responsible for the management of 
their condition.  Psychosocial support for such patients and their 
families should also be reinforced. There should also be greater 
collaboration between healthcare professionals working in health 
centres, hospitals and in the private sector.
discussion
levels of prevention
Strategies for preventing T2DM can be implemented at all the five 
different levels of prevention.
1.     Primordial prevention entails prevention of the disease prior 
to the presence of a modifiable risk factor. In this case, one 
would, for instance, aim to maintain a healthy weight since 
being obese is a significant risk factor for T2DM.
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Type 2 Diabetes Mellitus (T2DM) is a major health 
problem in Malta. Prevention strategies should focus 
on patient self-management skills, including a more 
active lifestyle and a balanced diet. The setting-up of a 
diabetes register would allow for a recall system leading 
to better follow-up and care of T2DM patients.
2.     Primary prevention2 involves preventing the onset of disease 
in those patients who are at risk.  Patients who have impaired 
fasting glucose (IFG) or impaired glucose tolerance (IGT) are 
at risk of developing T2DM and should be closely monitored 
in the community.  IFG is defined by an elevated fasting 
plasma glucose (FPG) concentration (≥100 and <126 mg/
dl), IGT is defined by an elevated 2-hour plasma glucose 
concentration (≥140 and <200 mg/dl) after a 75g oral 
glucose tolerance test (OGTT) in the presence of an FPG 
concentration <126 mg/dl.3
3.     Secondary prevention involves the prevention of 
complications in those with established disease. This 
incorporates the prevention of diabetic neuropathy, 
retinopathy and nephropathy by regular assessment of such 
patients and referral for specialist care when appropriate.
4.     Tertiary prevention entails reducing the risk of complications 
progressing further. For instance, a patient with background 
retinopathy should be followed-up in order to prevent the 
progression to pre-proliferative and proliferative retinopathy.
5.     Quaternary prevention is an increasingly important theme in 
family medicine and refers to various means of rehabilitation 
and restoring function whilst preventing ‘overmedicalisation’, 
particularly in the elderly population. 
Diabetes has a long preclinical phase (‘prediabetes’) 
which ranges from around 10 to 12 years. This provides an 
opportunity to exert effective preventive measures in order to 
delay the development of disease. Furthermore, individuals with 
undiagnosed diabetes who are experiencing symptoms (such 
as polyuria, polydipsia and weight loss) should be worked up 
immediately in order to limit the onset of comorbidities.
Unlike other diseases, the diagnosis of diabetes only requires 
a simple blood test, hence making the diagnostic process simple, 
cheap and convenient for both the clinician and the patient.  
Therefore, patients who present to their GP for a routine check-up 
should be encouraged to have their blood glucose tested regularly 
in order to establish their glycaemic status and address any 
problems when they are still in their infancy.
Several interventional studies4,5 demonstrate that lifestyle 
interventions and weight loss can actually prevent the onset of 
T2DM. The Diabetes Prevention Programme (DPP) trial showed 
that moderate weight loss, dietary changes and physical activity 
reduced the likelihood of patients with prediabetes to progress to 
T2DM by 58%.
curbing tHe diabetes epideMic in tHe coMMunity setting
Two main areas that should be targeted are an increase in physical 
exercise at a national level and dietary changes.6 The IDF explicitly 
states that “Physical activity is one of the main pillars in the 
prevention of diabetes”.7 It also states that 30 minutes of exercise a 
day can reduce the risk of diabetes by 40%.8
In a study by Ekelund at al9 it was shown that the health 
benefit of exercise is approximately double the expected health 
benefit arising from a reduction in obesity. Further to this, the 
UK Academy of Medicine studied the positive impact that regular 
physical activity could have on the nation’s health. It was found 
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that 30 minutes of physical activity five times a week can actually 
prevent the onset of T2DM. In view of this, family physicians 
should be motivated to prescribe physical activity to their patients 
from early life to middle and old age.  
Patients should also be actively encouraged by their family 
physician to follow certain simple rules with regards to a healthy 
balanced diet, such as:
•	 Including more whole grains (which are a good source of fibre) 
and lean sources of protein, particularly fish and vegetables; 
•	 Avoiding white bread, white rice, mashed potatoes, processed 
meats, cakes and sweets;
•	 Avoiding products containing partially hydrogenated vegetable 
oils as found in margarines, packaged baked goods and fried 
foods. These should be substituted by polyunsaturated fats as 
found in liquid vegetable oils, nuts and seeds and, in particular, 
those found in fish;
•	 Avoiding breakfast cereals which contain sugar or which have 
a high glycaemic index. Soft beverages should be substituted by 
water, coffee or tea;
•	 Avoiding both active and passive smoking.
Above all, developing patient self-management skills is the way 
forward to effectively manage and care for diabetes. This means 
that doctors should empower their patients to learn about their 
condition and be able to independently control their blood glucose 
levels. This places patients at the centre of healthcare provision, as 
opposed to the paternalistic approach in which patients do not have 
an active role in managing their own conditions.
screening 
T2DM fulfils a number of criteria which makes it an excellent 
candidate for screening high risk populations. It has a large and 
growing disease burden, its natural history is well understood 
and there is a long asymptomatic pre-diabetic state. Screening 
for T2DM is low cost, safe and reliable. Such considerations are 
important in view of the fact that T2DM is a treatable disease and 
benefits from early treatment.  
Earlier detection through screening policies represents a 
pivotal ‘paradigm shift’ for diabetes prevention.10 Screening 
provides the entry point for T2DM prevention in patients with 
prediabetes, thus contributing to the avoidance of complications 
in previously undiagnosed patients with T2DM.
inforMation systeMs for t2dM patients
A diabetes clinical information system has been in place for 
a number of years at the diabetes clinic since the 1990s, formerly 
at St Luke’s Hospital and now at Mater Dei Hospital. This system 
forms part of a database building project, the European Shared 
Diabetes information system. It allows for online consultation with 
respective consultants at Mater Dei and advice on management 
is given without the need to refer patients for appointments.11 
However, this information system is not comprehensive since not 
all clinicians make use of the system and the system is not available 
to private family doctors. An ICT-based register of patients with 
diabetes would allow for integrated care between public hospitals 
and the community setting (health centres and the private sector). 
This would enable greater continuity of care amongst healthcare 
professionals and improve follow-up. 
tHe way forward
T2DM is an ideal condition for screening.  It is being proposed 
that, at least every two years, screening is carried out in health 
centres or in private clinics in those patients who have at least one 
of the following risk factors. 
•	 Obese patients (BMI >=30 kg/m2) over 18 years of age; 
•	 Overweight patients (BMI 25–29.9 kg/m2) between the age of 
18 and 44 with a family history of diabetes;
•	 All patients above the age of 45; 
•	 Adults with a systolic blood pressure greater than 130mmHg 
and/or cardiovascular disease;
•	 Previous occurrence of diabetes in pregnancy; 
•	 Patients who are on medications that predispose to T2DM.  
Such drugs include nicotinic acid, glucocorticoids, thiazides, 
phenytoin and anti-psychotics.
 conclusion
The care given to T2DM patients should address the biological 
as well as the psychosocial aspects of the condition. Healthcare 
professionals caring for patients with diabetes should be trained to 
recognise signs and symptoms of psychological distress. Patients 
with poor social support should be appropriately referred to 
psychologists and social workers since social exclusion renders 
management of diabetes even more difficult. Holistic care can only 
be achieved when patients are cared for by a multidisciplinary 
team consisting of doctors, diabetes nurse specialists, dieticians, 
podiatrists and psychologists.  
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